Kerry completed his PhD in Medical Statistics part-time, whilst working as a Statistician in the National Health Service in the UK. Following spells with Ciba-Geigy AG (now Novartis) in Basel, Switzerland and the University of Kent at Canterbury, UK, Kerry joined Quintiles in Bracknell, UK in 1993. He has gained considerable experience in the design, analysis and reporting of pre-clinical as well as Phase I, II, III and IV clinical trials, across a very wide range of therapeutic areas. He has been particularly involved with regulatory submissions in diabetes, migraine, Parkinson’s disease, transplantation and vaccines.